The dysregulation of SLC13A1 and SLC6A19 are reported to affect various type of tumor progression including ccRCC (Horinouchi et al., 2010; Bogatikov et al., 2012; Choudhury et al., 2015). This evidence concerns the gene SLC6A19 and neoplasm.